New research highlights Transpara Detection’s impact on the MASAI trial’s final endpoint: interval cancers , /PRNewswire/ — ScreenPoint Medical, The […]
, /PRNewswire/ — Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is […]